SlideShare a Scribd company logo
1 of 43
SEMINAR ON
Approach to a child with fever
Alebachew (R3)
For HO students
1
Alebachew R3
3/3/2024
OUT LINE
 Objective
 Introduction
 Pathogenesis of fever
Mechanism
 Causes of fever
 Evaluation
Hx,P/e,Ix
 General management approach.
 Classification of fever in pediatrics.
 Reference .
3/3/2024 Alebachew R3 2
Introduction
 Fever
is an abnormal increase in body temperature that
results from elevation of the hypothalamic set-
point.
Is defined as a rectal temperature ≥38°C.
Normal range 36.6 - 37.9°C rectally.
Peak in the afternoon (5-7P.M) and lowest early
morning (2-6 A.M).
Has both positive and negative effects.
3
Alebachew R3
3/3/2024
Cont..
 Fever increases the basal metabolic rate by 10-12%
for each degree Celsius elevation of temperature .
This increases oxygen consumption, carbon
dioxide production, and fluid and caloric needs.
 Fluid requirements increase 100 mL/m2/day for
each 1°C rise in temperature above 37.8°C.
4
Alebachew R3
3/3/2024
Terminology
 Hyperpyrexia
A value >40°C.
 Indicates high probability of hypothalamic disorders or CNS
hemorrhage and should be treated with antipyretics.
 Hyperthermia
Is an abnormal elevation of body temperature that occurs without a
change in the thermoregulatory set point in the hypothalamus.
 This failure of normal homeostasis results in heat production that
exceeds the body's capacity for dissipation.
 Body temperature in patients with hyperthermia does not respond
to antipyretic agents.
 Malignant hyperthermia - susceptible to hyperthermia if
you receive a specific combination of sedatives and
anesthesia for medical procedures.
Alebachew R3 5
3/3/2024
Pathogenesis
3/3/2024 Alebachew R3 6
Pyrogens
Production of IL-1,IL-
6,TNF,IFN-betha,gama by
phagocyte cell in blood,
tissue.
Carried to
anterior
Hypothalamus
Synthesis of
prostaglandins
(PGE2)
Raise hypothalamic
set point for
temperature
fever
induce
induc
e
Mechanisms Of fever
1-Pyrogens,
Endogenous pyrogens
o IL-1 , IL-6,TNF-α, IFN-β and IFN-γ.
Exogenous pyrogens
o infectious pathogens and drugs.
Endotoxin
2- Heat production exceeding heat loss (E.g-
salicylate poisoning , malignant hyperthermia).
3- Defective heat loss.
7
Alebachew R3
3/3/2024
Cont..
 Euthermia
 Hypothalamic set-point
and body temperature
set-point normal.
 Fever
 Hypothalamic and body
temperature set-point
elevated.
 Heatillness
 Hypothalamic set-point
is normal but body
temperature set point is
elevated.
8
Alebachew R3
3/3/2024
Temperature Measurement
 Site and method of measurement
• Most common sites in clinical practice are
• Rectum,
• Mouth, and
• Axilla
1-Rectal thermometry
Reference/gold standard for measurement of
core body temperature for < 3years of age or
younger.
Contraindicated in patients with neutropenia.
9
Alebachew R3
3/3/2024
Cont..
2- Oral thermometry
 Is preferred in children who are old enough to
cooperate.
 Is typically 0.6°C (1.0°F) lower than rectal temperature
because of mouth breathing.
Affected by recent ingestion of hot or cold liquids.
10
Alebachew R3
3/3/2024
Cont..
3- Axillary thermometry
Are commonly used.
Less precise than rectal temperatures.
Correlation axillary temperature is
usually 0.5-0.85°C lower than rectal.
11
Alebachew R3
3/3/2024
Cont..
4-Contact and noncontact infrared tympanic
membrane (TM) thermometry.
Measure the amount of heat produced by the TM.
Temperature readings are close to core
temperature
5-Temporal artery temperature measurement
 Infrared contact and noncontact forehead
thermometers measure the amount of heat produced
by the temporal arteries.
6- Smart phones
absence of adequate study, they cannot be
recommended for use.
12
Alebachew R3
3/3/2024
Cont..
When detection of fever is critical for
diagnosis and management, rectal
temperatures should be used in the
child 3 years of age and younger.
13
Alebachew R3
3/3/2024
Causes of fever
 4 main categories…
 Infectious,
Inflammatory,
Neoplastic
Miscellaneous.
14
Alebachew R3
3/3/2024
Pattern of fever
1-Intermittent fever- rises for a few hours each days and decline
to normal in the same day before rising again.
2- Sustained fever- is persistent and does not vary by
>0.5°C/day.
3- Remittent fever- is persistent and varies by >0.5°C/day . But
never fall all the way to normal.
4- Relapsing fever- rises for a variable period and
declines to normal for a days before rising again.
5- Tertian fever- occurs on the 1st and 3rd days (E.g- vivax ).
6-Quartan fever- occurs on the 1st and 4th days (E.g- malariae).
7-Periodic fever- describe fever syndromes with a regular periodicity.
8-Double quotidian fever- fever that peaks twice in 24 hr.
15
Alebachew R3
3/3/2024
Evaluation
 History
 Onset (acute , chronic)
 Pattern of fever
 Cough , chest pain (Pneumonia).
 PND, Orthopenia,palpitation,fatigability (ARF, IE, myocardities).
 Headache ,neck stuffiness , vomiting,irritability  mengitis
 Ear pian , discharge ototis media
 Rash  (meningococcemia , IE).
 Travel history (malaria ,VL, Hepatitis, Typhoid Fever ,Tuberculosis
, Amebiasis).
 Medications ( vancomycin, amphotericin B, allopurinol).
 Past medical history(chronic illness).
 Vaccines hx.
 Exposures (daycare, school, family, pets, playmates) .
 Decreased appetite, bone pain , weight loss  malignancy
 Dysuria, back pain  febrile UTI.
16
Alebachew R3
3/3/2024
Cont..
 Physical examination
• Vital signs
Tachycardia
Relative bradycardia (typhoid fever, brucellosis,
leptospirosis).
Pulse oximetry  (cardiac, respiratory origin).
• Anthropometry
• Head to toe…
17
Alebachew R3
3/3/2024
Cont..
 Eye
 Conjunctivitis,uveitis (Kawasakidisease,SLE), polyarteritis
nodosa, JIA, Sarcoidosis).
 Chorioretinitis  CMV
 Atrophic spots focal granulomas of the retina and choroid
Histoplasmosis .
 Ears, Nose, and Throat
 Teeth and gums  dental abscess.
 Tympanic membranes , mastiod tenderness  AOM.
 Nares ( inflamed mucosa and purulent discharge) 
common cold.
 Exudative and non exudative pharyngitis  (EBV, tularemia
, leptospirosis and CMV).
Alebachew R3 18
3/3/2024
Cont..
 Neck
Adenopathy  (CMV,EBV, systemic JIA , RVI,
Lymphoma, leukemia, TB lymphadenitis).
 RS
Localized chest finding  (pneumonia,…).
 CVS
 Cardiac lesion(E.g-MR,AR) (IE , ARF , viral
myocarditis).
Alebachew R3 19
3/3/2024
Cont..
 Abdomen
 Masses or hepato-splenomegaly  (malaria ,VL ,lymphoma ,
leukemia).
 Abdominal tenderness (peritonitis,PID).
 GUS
 Coast vertebral angle tenderness  febrile UTI.
 Musculoskeletal
 Warmth, tenderness ,or swelling of joints septic arthritis,
ARF,…).
 Pain on palpation over a bone (neoplastic infiltration,
sickle cell anemia).
Alebachew R3 20
3/3/2024
Cont..
 Skin
Evanescent , salmon-colored macular rash over the
trunk and joints JIA.
 Heliotropic rash of the upper eyelids, Gottron
sign  Dermatomyositis.
Malar rash , photosensitivity in sun-exposed areas 
SLE.
Splinter hemorrhages or Janeway lesions (painless,
small, erythematous or hemorrhagic lesions on the
palms and soles)IE.
 CNS- nuchal rigidity, meningial signs.
Alebachew R3 21
3/3/2024
Cont..
 Laboratory studies (case based).
Rapid antigen testing.
polymerase chain reaction (PCR).
Stool.
Blood: CBC, blood culture, CRP, ESR, procalcitonin,BF.
Urine.
 LP (CSF).
 CXR.
22
Alebachew R3
3/3/2024
General management approach
 Encouraging good hydration
 External cooling
 Antipyretic agents.
Fever with temperatures <39°C in healthy
children generally does not require
treatment.
Should be treated only in select
circumstances.
23
Alebachew R3
3/3/2024
Cont…
 Indications to start antipyretics
Shock,
Underlying neurologic or cardiopulmonary disease, or
other condition with increased metabolic rate (eg,
burn, postoperative state).
Alteration in fluid and electrolyte balance.
High fever  ≥39°C .
Discomfort / child's caregiver is concerned.
Major head trauma.
Post cardiac arrest.
24
Alebachew R3
3/3/2024
Cont..
The most common antipyretics are
Acetaminophen -10-15 mg/kg/dose every 4 hr, and
Iibuprofen - in children >6 mo old at 5-10 mg/kg/dose
every 8 hr.
Combining or alternating therapy
Do not suggest combining or alternating therapy
with acetaminophen and ibuprofen to treat fever in
children.
Although combining or alternating acetaminophen and
ibuprofen may be more effective than either agent
alone in reducing fever, it is not clear that this
reduction is clinically significant.
25
Alebachew R3
3/3/2024
Mechanism of action of antipyretics
 It is now clear that most antipyretics work by
inhibiting the enzyme cyclooxygenase and reducing
the levels of PGE2 within the hypothalamus.
 Recently, other mechanisms of action
Reduce pro inflammatory mediators,
Enhance anti-inflammatory signals at sites of
injury,
Boost antipyretic messages within the brain.
26
Alebachew R3
3/3/2024
Mechanism of action of PCM
3/3/2024 Alebachew R3 27
External cooling
 Is the treatment of choice for heat stroke and other
forms of heat illness in which rapid cooling is
necessary to prevent end-organ damage.
 Do not routinely suggest external cooling for
temperature reduction in previously well infants and
children with a febrile illness.
 In RCT comparing the combination of tepid
sponging and antipyretic therapy to antipyretic
therapy alone, the added benefit of tepid sponging in
temperature reduction was short-lived, and sponging
was associated with increased discomfort.
Alebachew R3 28
3/3/2024
Cont..
 External cooling may be used as an adjunct to
antipyretic therapy for children in whom more rapid
and greater reduction of body temperature is
necessary than can be achieved with antipyretic
agents alone.
 In such cases, antipyretic agents should be
administered at least 30 minutes before external
cooling to reset the thermoregulatory set-point,
without which external cooling will result in an
increase in heat production.
Alebachew R3 29
3/3/2024
Cont..
 Possible indications for concomitant
antipyretic administration and mechanical
cooling…
Uncertainty about the cause of elevated temperature
(heat illness versus fever).
Fever combined with a component of heat illness (eg,
from over-wrapping, hypovolemia, or drugs such
as atropine).
 Underlying neurologic disorder, in which the child may
have abnormal temperature control and poor response
to antipyretic agents.
Alebachew R3 30
3/3/2024
Cont..
 When mechanical cooling is necessary to treat fever,
we suggest sponging with comfortably warm or
tepid water around 30°C.
 Sponging is more effective than immersion because
evaporation from the skin augments heat loss.
 N.B- Alcohol should not be used because its fumes
are absorbed across the alveolar membrane and
possibly across the skin, resulting in CNS toxicity.
Alebachew R3 31
3/3/2024
Fever in the pediatric population
 Is usually grouped in to 4 categories:
Fever Without a Focus in the Neonate
and Young Infant.
 Fever in the Older Child.
Fever with out source (FWS).
Fever of unknown origin (FUO)
32
Alebachew R3
3/3/2024
1-Fever Without a Focus in the Neonate
and Young Infant
• Refers to a rectal temperature of >/=38°C
without other presenting signs or symptoms.
• Age groups
Neonates 0-28 days,
 Young infants 29-90 days.
3/3/2024 Alebachew R3 33
Etiology and Epidemiology
• Serious bacterial infection ( 7% - 13%).
UTI ( 5–13%)  The most common.
Bacteremia (1–2%) and
 Meningitis (0.2–0.5%).
• The most common organism.
 Escherichia coli first
GBS  the second .
• less common organisms
Klebsiella spp.,
Enterococcus spp.,
Streptococcus pneumoniae ,
 Neisseria meningitidis , and
Staphylococcus aureus
• Rare  Listeria monocytogenes .
3/3/2024 Alebachew R3 34
Diagnosis
 Traditionally,
– All neonates <60 or <90 days of age were hospitalized.
 Underwent laboratory evaluation
 Blood, urine, CSF and stool cultures,CXR.
 Received empirical antibiotics ,, HSV evaluation,
 Empirical antiviral agents.
 But ,Protocols were subsequently developed to identify
infants at lower risk of SBI.
 The 3 most widely used criteria are…
 The Rochester,
 Philadelphia, and
 Boston criteria
3/3/2024 Alebachew R3 35
3/3/2024 Alebachew R3 36
Cont..
3/3/2024 Alebachew R3 37
Cont..
3/3/2024 Alebachew R3 38
2-Fever in the Older Child
 Pediatricians can rely more readily on symptoms
and physical examination findings to establish a
diagnosis.
• Potential causes
– Common
• viral (most common ) and
• bacterial infections
– less common
• Inflammatory,
• Oncologic,
• Endocrine, and
• Medication induced
3/3/2024 Alebachew R3 39
3-Fever of Unknown Origin(FUO)
• Is defined as a temperature >38°C
documented by a healthcare provider and for
which the cause could not be identified after
at least 8 days of evaluation
• Is usually an uncommon presentation of a
common disease.
3/3/2024 Alebachew R3 40
Cont…
• FUO has 4 Subtypes…
Classic FUO - >38°C , >3 wk, >2 visits or 1 wk in hospital.
Healthcare associated FUO - ≥38°C , >1 wk, not
present or incubating on admission.
Immune deficient FUO - ≥38°C , >1 wk, negative
cultures after 48 hr.
HIV-related FUO -≥38°C , >3 wk for outpatients,
>1 wk for inpatients, HIV infection confirmed.
3/3/2024 Alebachew R3 41
4-Fever without a source (FWS).
• A temperature >38°C where the source has
not yet been identified with in 7 days.
• Can progress to FUO if no cause is elicited
after 7days of evaluation.
3/3/2024 Alebachew R3 42
Reference
• Linda S. Nield, Deepak Kamat, Nelsone text
book of pediatrics 21st edition fever, chapter
201.
• Up-to-date 2022.
3/3/2024 Alebachew R3 43

More Related Content

Similar to Approach to fever in childern ppt (Ho).pptx

Fever & hyperthermia
Fever & hyperthermiaFever & hyperthermia
Fever & hyperthermia
Kurian Joseph
 

Similar to Approach to fever in childern ppt (Ho).pptx (20)

Acute Rheumatic Fever.ppt
Acute Rheumatic Fever.pptAcute Rheumatic Fever.ppt
Acute Rheumatic Fever.ppt
 
Fever in icu
Fever in icuFever in icu
Fever in icu
 
Fever in icu
Fever in icuFever in icu
Fever in icu
 
Fever in icu
Fever in icuFever in icu
Fever in icu
 
FEVER IN ICU
FEVER IN ICUFEVER IN ICU
FEVER IN ICU
 
vitalsign-1238487877784518787845148.pptx
vitalsign-1238487877784518787845148.pptxvitalsign-1238487877784518787845148.pptx
vitalsign-1238487877784518787845148.pptx
 
Babitha's Note on vital signs
Babitha's Note on vital signsBabitha's Note on vital signs
Babitha's Note on vital signs
 
Introduction To Fever & Fuo
Introduction To Fever & FuoIntroduction To Fever & Fuo
Introduction To Fever & Fuo
 
Basics of Fever in Pediatrics
Basics of Fever in Pediatrics Basics of Fever in Pediatrics
Basics of Fever in Pediatrics
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
 
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdfapproachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
approachtohistorytakinginapatientwithfever-121012050419-phpapp02.pdf
 
BODY TEMP..pdf
BODY TEMP..pdfBODY TEMP..pdf
BODY TEMP..pdf
 
Therapeutic hypothermia during neonatal transport – feasibility and
Therapeutic hypothermia during neonatal transport – feasibility andTherapeutic hypothermia during neonatal transport – feasibility and
Therapeutic hypothermia during neonatal transport – feasibility and
 
Fever & hyperthermia
Fever & hyperthermiaFever & hyperthermia
Fever & hyperthermia
 
Fever IN ICU.pptx
Fever IN ICU.pptxFever IN ICU.pptx
Fever IN ICU.pptx
 
Fever in Children .pptx
Fever in Children .pptxFever in Children .pptx
Fever in Children .pptx
 
Therapeutic cooling during neonatal transport
Therapeutic cooling during neonatal transportTherapeutic cooling during neonatal transport
Therapeutic cooling during neonatal transport
 
Temperature regulation disorders
Temperature regulation disordersTemperature regulation disorders
Temperature regulation disorders
 
Rheumatic fever and Rheumatic heart disease
Rheumatic fever and Rheumatic heart diseaseRheumatic fever and Rheumatic heart disease
Rheumatic fever and Rheumatic heart disease
 
Fever in icu
Fever in icuFever in icu
Fever in icu
 

More from BekaluTemesgen2 (8)

Presentation 2 toxoplasmosis and(1).pptx
Presentation 2 toxoplasmosis and(1).pptxPresentation 2 toxoplasmosis and(1).pptx
Presentation 2 toxoplasmosis and(1).pptx
 
Presentation 1 (1kkkkkkkkkkkkkkkkkkkk).pptx
Presentation 1 (1kkkkkkkkkkkkkkkkkkkk).pptxPresentation 1 (1kkkkkkkkkkkkkkkkkkkk).pptx
Presentation 1 (1kkkkkkkkkkkkkkkkkkkk).pptx
 
Presentation 2this is a power point about toxoplasmosis.pptx
Presentation 2this is a power point about toxoplasmosis.pptxPresentation 2this is a power point about toxoplasmosis.pptx
Presentation 2this is a power point about toxoplasmosis.pptx
 
UTI power point about urinary tract infection .pptx
UTI power point about urinary tract infection .pptxUTI power point about urinary tract infection .pptx
UTI power point about urinary tract infection .pptx
 
bacterial infection part 2 and about their managments.pptx
bacterial infection part 2 and about their managments.pptxbacterial infection part 2 and about their managments.pptx
bacterial infection part 2 and about their managments.pptx
 
anemiappt-210812153032 and management .pdf
anemiappt-210812153032 and management .pdfanemiappt-210812153032 and management .pdf
anemiappt-210812153032 and management .pdf
 
2. shock.pptx and this is a power point on shock
2. shock.pptx and this is a power point on shock2. shock.pptx and this is a power point on shock
2. shock.pptx and this is a power point on shock
 
8. Acute Kidney Injury.pptx short power point about aki
8. Acute Kidney Injury.pptx  short power point about aki8. Acute Kidney Injury.pptx  short power point about aki
8. Acute Kidney Injury.pptx short power point about aki
 

Recently uploaded

Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
Naveen Gokul Dr
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 

Recently uploaded (20)

Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
 
Young & Hot Surat ℂall Girls Vesu 8527049040 WhatsApp AnyTime Best Surat ℂall...
Young & Hot Surat ℂall Girls Vesu 8527049040 WhatsApp AnyTime Best Surat ℂall...Young & Hot Surat ℂall Girls Vesu 8527049040 WhatsApp AnyTime Best Surat ℂall...
Young & Hot Surat ℂall Girls Vesu 8527049040 WhatsApp AnyTime Best Surat ℂall...
 
Young & Hot Surat ℂall Girls Dindoli 8527049040 WhatsApp AnyTime Best Surat ℂ...
Young & Hot Surat ℂall Girls Dindoli 8527049040 WhatsApp AnyTime Best Surat ℂ...Young & Hot Surat ℂall Girls Dindoli 8527049040 WhatsApp AnyTime Best Surat ℂ...
Young & Hot Surat ℂall Girls Dindoli 8527049040 WhatsApp AnyTime Best Surat ℂ...
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
 
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
VIP ℂall Girls Kandivali west Mumbai 8250077686 WhatsApp: Me All Time Serviℂe...
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 

Approach to fever in childern ppt (Ho).pptx

  • 1. SEMINAR ON Approach to a child with fever Alebachew (R3) For HO students 1 Alebachew R3 3/3/2024
  • 2. OUT LINE  Objective  Introduction  Pathogenesis of fever Mechanism  Causes of fever  Evaluation Hx,P/e,Ix  General management approach.  Classification of fever in pediatrics.  Reference . 3/3/2024 Alebachew R3 2
  • 3. Introduction  Fever is an abnormal increase in body temperature that results from elevation of the hypothalamic set- point. Is defined as a rectal temperature ≥38°C. Normal range 36.6 - 37.9°C rectally. Peak in the afternoon (5-7P.M) and lowest early morning (2-6 A.M). Has both positive and negative effects. 3 Alebachew R3 3/3/2024
  • 4. Cont..  Fever increases the basal metabolic rate by 10-12% for each degree Celsius elevation of temperature . This increases oxygen consumption, carbon dioxide production, and fluid and caloric needs.  Fluid requirements increase 100 mL/m2/day for each 1°C rise in temperature above 37.8°C. 4 Alebachew R3 3/3/2024
  • 5. Terminology  Hyperpyrexia A value >40°C.  Indicates high probability of hypothalamic disorders or CNS hemorrhage and should be treated with antipyretics.  Hyperthermia Is an abnormal elevation of body temperature that occurs without a change in the thermoregulatory set point in the hypothalamus.  This failure of normal homeostasis results in heat production that exceeds the body's capacity for dissipation.  Body temperature in patients with hyperthermia does not respond to antipyretic agents.  Malignant hyperthermia - susceptible to hyperthermia if you receive a specific combination of sedatives and anesthesia for medical procedures. Alebachew R3 5 3/3/2024
  • 6. Pathogenesis 3/3/2024 Alebachew R3 6 Pyrogens Production of IL-1,IL- 6,TNF,IFN-betha,gama by phagocyte cell in blood, tissue. Carried to anterior Hypothalamus Synthesis of prostaglandins (PGE2) Raise hypothalamic set point for temperature fever induce induc e
  • 7. Mechanisms Of fever 1-Pyrogens, Endogenous pyrogens o IL-1 , IL-6,TNF-α, IFN-β and IFN-γ. Exogenous pyrogens o infectious pathogens and drugs. Endotoxin 2- Heat production exceeding heat loss (E.g- salicylate poisoning , malignant hyperthermia). 3- Defective heat loss. 7 Alebachew R3 3/3/2024
  • 8. Cont..  Euthermia  Hypothalamic set-point and body temperature set-point normal.  Fever  Hypothalamic and body temperature set-point elevated.  Heatillness  Hypothalamic set-point is normal but body temperature set point is elevated. 8 Alebachew R3 3/3/2024
  • 9. Temperature Measurement  Site and method of measurement • Most common sites in clinical practice are • Rectum, • Mouth, and • Axilla 1-Rectal thermometry Reference/gold standard for measurement of core body temperature for < 3years of age or younger. Contraindicated in patients with neutropenia. 9 Alebachew R3 3/3/2024
  • 10. Cont.. 2- Oral thermometry  Is preferred in children who are old enough to cooperate.  Is typically 0.6°C (1.0°F) lower than rectal temperature because of mouth breathing. Affected by recent ingestion of hot or cold liquids. 10 Alebachew R3 3/3/2024
  • 11. Cont.. 3- Axillary thermometry Are commonly used. Less precise than rectal temperatures. Correlation axillary temperature is usually 0.5-0.85°C lower than rectal. 11 Alebachew R3 3/3/2024
  • 12. Cont.. 4-Contact and noncontact infrared tympanic membrane (TM) thermometry. Measure the amount of heat produced by the TM. Temperature readings are close to core temperature 5-Temporal artery temperature measurement  Infrared contact and noncontact forehead thermometers measure the amount of heat produced by the temporal arteries. 6- Smart phones absence of adequate study, they cannot be recommended for use. 12 Alebachew R3 3/3/2024
  • 13. Cont.. When detection of fever is critical for diagnosis and management, rectal temperatures should be used in the child 3 years of age and younger. 13 Alebachew R3 3/3/2024
  • 14. Causes of fever  4 main categories…  Infectious, Inflammatory, Neoplastic Miscellaneous. 14 Alebachew R3 3/3/2024
  • 15. Pattern of fever 1-Intermittent fever- rises for a few hours each days and decline to normal in the same day before rising again. 2- Sustained fever- is persistent and does not vary by >0.5°C/day. 3- Remittent fever- is persistent and varies by >0.5°C/day . But never fall all the way to normal. 4- Relapsing fever- rises for a variable period and declines to normal for a days before rising again. 5- Tertian fever- occurs on the 1st and 3rd days (E.g- vivax ). 6-Quartan fever- occurs on the 1st and 4th days (E.g- malariae). 7-Periodic fever- describe fever syndromes with a regular periodicity. 8-Double quotidian fever- fever that peaks twice in 24 hr. 15 Alebachew R3 3/3/2024
  • 16. Evaluation  History  Onset (acute , chronic)  Pattern of fever  Cough , chest pain (Pneumonia).  PND, Orthopenia,palpitation,fatigability (ARF, IE, myocardities).  Headache ,neck stuffiness , vomiting,irritability  mengitis  Ear pian , discharge ototis media  Rash  (meningococcemia , IE).  Travel history (malaria ,VL, Hepatitis, Typhoid Fever ,Tuberculosis , Amebiasis).  Medications ( vancomycin, amphotericin B, allopurinol).  Past medical history(chronic illness).  Vaccines hx.  Exposures (daycare, school, family, pets, playmates) .  Decreased appetite, bone pain , weight loss  malignancy  Dysuria, back pain  febrile UTI. 16 Alebachew R3 3/3/2024
  • 17. Cont..  Physical examination • Vital signs Tachycardia Relative bradycardia (typhoid fever, brucellosis, leptospirosis). Pulse oximetry  (cardiac, respiratory origin). • Anthropometry • Head to toe… 17 Alebachew R3 3/3/2024
  • 18. Cont..  Eye  Conjunctivitis,uveitis (Kawasakidisease,SLE), polyarteritis nodosa, JIA, Sarcoidosis).  Chorioretinitis  CMV  Atrophic spots focal granulomas of the retina and choroid Histoplasmosis .  Ears, Nose, and Throat  Teeth and gums  dental abscess.  Tympanic membranes , mastiod tenderness  AOM.  Nares ( inflamed mucosa and purulent discharge)  common cold.  Exudative and non exudative pharyngitis  (EBV, tularemia , leptospirosis and CMV). Alebachew R3 18 3/3/2024
  • 19. Cont..  Neck Adenopathy  (CMV,EBV, systemic JIA , RVI, Lymphoma, leukemia, TB lymphadenitis).  RS Localized chest finding  (pneumonia,…).  CVS  Cardiac lesion(E.g-MR,AR) (IE , ARF , viral myocarditis). Alebachew R3 19 3/3/2024
  • 20. Cont..  Abdomen  Masses or hepato-splenomegaly  (malaria ,VL ,lymphoma , leukemia).  Abdominal tenderness (peritonitis,PID).  GUS  Coast vertebral angle tenderness  febrile UTI.  Musculoskeletal  Warmth, tenderness ,or swelling of joints septic arthritis, ARF,…).  Pain on palpation over a bone (neoplastic infiltration, sickle cell anemia). Alebachew R3 20 3/3/2024
  • 21. Cont..  Skin Evanescent , salmon-colored macular rash over the trunk and joints JIA.  Heliotropic rash of the upper eyelids, Gottron sign  Dermatomyositis. Malar rash , photosensitivity in sun-exposed areas  SLE. Splinter hemorrhages or Janeway lesions (painless, small, erythematous or hemorrhagic lesions on the palms and soles)IE.  CNS- nuchal rigidity, meningial signs. Alebachew R3 21 3/3/2024
  • 22. Cont..  Laboratory studies (case based). Rapid antigen testing. polymerase chain reaction (PCR). Stool. Blood: CBC, blood culture, CRP, ESR, procalcitonin,BF. Urine.  LP (CSF).  CXR. 22 Alebachew R3 3/3/2024
  • 23. General management approach  Encouraging good hydration  External cooling  Antipyretic agents. Fever with temperatures <39°C in healthy children generally does not require treatment. Should be treated only in select circumstances. 23 Alebachew R3 3/3/2024
  • 24. Cont…  Indications to start antipyretics Shock, Underlying neurologic or cardiopulmonary disease, or other condition with increased metabolic rate (eg, burn, postoperative state). Alteration in fluid and electrolyte balance. High fever  ≥39°C . Discomfort / child's caregiver is concerned. Major head trauma. Post cardiac arrest. 24 Alebachew R3 3/3/2024
  • 25. Cont.. The most common antipyretics are Acetaminophen -10-15 mg/kg/dose every 4 hr, and Iibuprofen - in children >6 mo old at 5-10 mg/kg/dose every 8 hr. Combining or alternating therapy Do not suggest combining or alternating therapy with acetaminophen and ibuprofen to treat fever in children. Although combining or alternating acetaminophen and ibuprofen may be more effective than either agent alone in reducing fever, it is not clear that this reduction is clinically significant. 25 Alebachew R3 3/3/2024
  • 26. Mechanism of action of antipyretics  It is now clear that most antipyretics work by inhibiting the enzyme cyclooxygenase and reducing the levels of PGE2 within the hypothalamus.  Recently, other mechanisms of action Reduce pro inflammatory mediators, Enhance anti-inflammatory signals at sites of injury, Boost antipyretic messages within the brain. 26 Alebachew R3 3/3/2024
  • 27. Mechanism of action of PCM 3/3/2024 Alebachew R3 27
  • 28. External cooling  Is the treatment of choice for heat stroke and other forms of heat illness in which rapid cooling is necessary to prevent end-organ damage.  Do not routinely suggest external cooling for temperature reduction in previously well infants and children with a febrile illness.  In RCT comparing the combination of tepid sponging and antipyretic therapy to antipyretic therapy alone, the added benefit of tepid sponging in temperature reduction was short-lived, and sponging was associated with increased discomfort. Alebachew R3 28 3/3/2024
  • 29. Cont..  External cooling may be used as an adjunct to antipyretic therapy for children in whom more rapid and greater reduction of body temperature is necessary than can be achieved with antipyretic agents alone.  In such cases, antipyretic agents should be administered at least 30 minutes before external cooling to reset the thermoregulatory set-point, without which external cooling will result in an increase in heat production. Alebachew R3 29 3/3/2024
  • 30. Cont..  Possible indications for concomitant antipyretic administration and mechanical cooling… Uncertainty about the cause of elevated temperature (heat illness versus fever). Fever combined with a component of heat illness (eg, from over-wrapping, hypovolemia, or drugs such as atropine).  Underlying neurologic disorder, in which the child may have abnormal temperature control and poor response to antipyretic agents. Alebachew R3 30 3/3/2024
  • 31. Cont..  When mechanical cooling is necessary to treat fever, we suggest sponging with comfortably warm or tepid water around 30°C.  Sponging is more effective than immersion because evaporation from the skin augments heat loss.  N.B- Alcohol should not be used because its fumes are absorbed across the alveolar membrane and possibly across the skin, resulting in CNS toxicity. Alebachew R3 31 3/3/2024
  • 32. Fever in the pediatric population  Is usually grouped in to 4 categories: Fever Without a Focus in the Neonate and Young Infant.  Fever in the Older Child. Fever with out source (FWS). Fever of unknown origin (FUO) 32 Alebachew R3 3/3/2024
  • 33. 1-Fever Without a Focus in the Neonate and Young Infant • Refers to a rectal temperature of >/=38°C without other presenting signs or symptoms. • Age groups Neonates 0-28 days,  Young infants 29-90 days. 3/3/2024 Alebachew R3 33
  • 34. Etiology and Epidemiology • Serious bacterial infection ( 7% - 13%). UTI ( 5–13%)  The most common. Bacteremia (1–2%) and  Meningitis (0.2–0.5%). • The most common organism.  Escherichia coli first GBS  the second . • less common organisms Klebsiella spp., Enterococcus spp., Streptococcus pneumoniae ,  Neisseria meningitidis , and Staphylococcus aureus • Rare  Listeria monocytogenes . 3/3/2024 Alebachew R3 34
  • 35. Diagnosis  Traditionally, – All neonates <60 or <90 days of age were hospitalized.  Underwent laboratory evaluation  Blood, urine, CSF and stool cultures,CXR.  Received empirical antibiotics ,, HSV evaluation,  Empirical antiviral agents.  But ,Protocols were subsequently developed to identify infants at lower risk of SBI.  The 3 most widely used criteria are…  The Rochester,  Philadelphia, and  Boston criteria 3/3/2024 Alebachew R3 35
  • 39. 2-Fever in the Older Child  Pediatricians can rely more readily on symptoms and physical examination findings to establish a diagnosis. • Potential causes – Common • viral (most common ) and • bacterial infections – less common • Inflammatory, • Oncologic, • Endocrine, and • Medication induced 3/3/2024 Alebachew R3 39
  • 40. 3-Fever of Unknown Origin(FUO) • Is defined as a temperature >38°C documented by a healthcare provider and for which the cause could not be identified after at least 8 days of evaluation • Is usually an uncommon presentation of a common disease. 3/3/2024 Alebachew R3 40
  • 41. Cont… • FUO has 4 Subtypes… Classic FUO - >38°C , >3 wk, >2 visits or 1 wk in hospital. Healthcare associated FUO - ≥38°C , >1 wk, not present or incubating on admission. Immune deficient FUO - ≥38°C , >1 wk, negative cultures after 48 hr. HIV-related FUO -≥38°C , >3 wk for outpatients, >1 wk for inpatients, HIV infection confirmed. 3/3/2024 Alebachew R3 41
  • 42. 4-Fever without a source (FWS). • A temperature >38°C where the source has not yet been identified with in 7 days. • Can progress to FUO if no cause is elicited after 7days of evaluation. 3/3/2024 Alebachew R3 42
  • 43. Reference • Linda S. Nield, Deepak Kamat, Nelsone text book of pediatrics 21st edition fever, chapter 201. • Up-to-date 2022. 3/3/2024 Alebachew R3 43